Validation of inflammation-based prognostic scores and haematological parameters to predict bladder cancer invasion  by Lee, S.M. et al.
Abstracts / International Journal of Surgery 23 (2015) S15eS134 S121Conclusion: The novel model outperformed the PCPT risk calculator in all
5 patient cohorts and can be used to improve clinical decision making in
Irish men under investigation for PCa.
0187: SINGLE CENTRE EXPERIENCE FROM THE ACCURACY OF
CONVENTIONAL 1.5 T MAGNETIC RESONANCE IMAGING FOR THE
DIAGNOSIS AND PRE-OPERATIVE STAGING OF PROSTATE CANCER
H. Raja*, D. Moschonas, N. Haldar, K. Misra, J. Kelleher. Buckinghamshire
Hospitals NHS Trust, UK
Aim: Not all trusts in the UK have 3T MRI scanners. Are patients with
suspected prostate cancer therefore adequately staged with a more con-
ventional 1.5T MRI scanner? The aim of the study was to evaluate the
accuracy of standard 1.5T MRI without endorectal coil for the staging of
prostate cancer compared against the histopathological results following
radical prostatectomy.
Methods: Prospective study enrolled 65 patients with biopsy-proven PCa
who underwent MRI prior to undergoing radical prostatectomy from
December 2012 to June 2014.
Results: Median times for patients having an MRI scan after TRUS biopsy
were 32.5 days. Preoperatively 38.5% of patients were diagnosed with T3/
T4 disease with MRI. The prevalence of pT3 and above prostate cancer
conﬁrmed histologically was 22/65 (33.84%). Postoperative down staging
was documented in 12/65 (18.46%) while upstaging in 9/65 (13.85%). The
sensitivity of MRI diagnosing T3 disease was 14/22 (63.63%), speciﬁcity 29/
43 (67.44%), accuracy 43/65 (66.15%)
Conclusion: Standard MRI detected 63.63% of all patients with T3 pros-
tate cancer, a crucial feature when planning deﬁnitive treatment. The
promising detection rate of our study, while being operator dependent,
offers a cost effective imaging modality for preoperative staging of
prostate cancer.
0188: A COMPARISON OF LEARNING CURVES IN ROBOTIC
PROSTATECTOMY WITHIN A CHANGING REFERRAL PRACTICE
A. Srinivasan 2,*, N.C. Shah 1, D.E. Neal 1, V.J. Gnanapragasam 1. 1Cambridge
University Hospitals Trust, UK; 2University of Cambridge, UK
Aim: Increased numbers of high-risk patients with advanced disease are
being treated with robotic prostatectomy (RP). We have explored the
impact of this on the learning curves and pathological outcomes of three
surgeons in a single RP tertiary unit.
Methods: Data was sourced from a prospective database and a previous
publication from our unit. Three periods corresponding to the ﬁrst and
second 50 cases of three surgeons (A: 2005-2006, B: 2008-2009, C: >2010)
were interrogated. One surgeon, (A), had prior extensive open RP
experience.
Results: Low-risk disease represented 55%, 33% and 25% of referrals in
periods A, B and C respectively while high-risk referrals accounted for 10%,
15% and 24% (p¼0.0001). Analysing cases 1-50 demonstrated declining
numbers of pT2 cases (A:74%, B:60% and C:46%) but an increase in pT3a
cases (A: 22%, B:34% and C:48%) and ﬁnal tumour volumes (A:9%, B:8% and
C:22%) (p¼0.002). Comparing cases 51-100 revealed identical trends.
Positive surgical margin (PSM) rates for cases 1-50 were A:12%, B:20% and
C:23% (p¼0.12). For cases 51-100 there was again no signiﬁcant difference
in PSM rates.
Conclusion: There is an increasing risk proﬁle amongst referred patients
which has however had minimal impact on pathological outcomes during
temporally different learning curves.
0237: PRESENCE OF DETRUSOR MUSCLE IN BLADDER TUMOUR
RESECTION: THE ROLE OF OPERATOR EXPERIENCE
S.M. Lee*, A. Russell, G. Hellawell. Northwick Park Hospital, UK
Aim: Detrusor muscle (DM) in transurethral resection of bladder
tumour (TURBT) specimens is a surrogate maker for resection quality.
Studies have suggested a correlation with the level of operating sur-
geon. We audited tumour and surgical factors related to detrusor
muscle sampling.Methods: Retrospective review of TURBT cases from 01/2011-01/2014 in a
district hospital. Demographics, tumour and surgical characteristics were
collected and analysed.
Results: 179 patients were included (mean age 71.2±12.2 years, mal-
e:female 141:38). Senior surgeons performed 129 (72.1%) resections. All
TURBTs were performed on dedicated lists with a senior surgeon super-
vising. DM was present in 140 (78.2%) samples. Within the cohort, there
was no signiﬁcant difference in recurrence rate when DMwas not sampled
(OR 1.315, 95%CI 0.617-2.805, p¼0.479).
Demographics for junior/senior surgeons signiﬁcantly differed for ASA
Grade, tumourmultiplicity and location. No difference in DM resectionwas
identiﬁed between junior/senior surgeons. Univariate analysis identiﬁed
that DM was less likely to be sampled in high grade (G3) tumours (versus
G1/G2, OR 0.345,p¼0.018*).
Conclusion: In contrast to previous studies, DM resection rates were not
inﬂuenced by surgeon level. Impact of operator experience may be miti-
gated through the use of dedicated TURBT lists and direct senior super-
vision, although further investigation is needed.
0239: VALIDATION OF INFLAMMATION-BASED PROGNOSTIC SCORES
AND HAEMATOLOGICAL PARAMETERS TO PREDICT BLADDER CANCER
INVASION
S.M. Lee*, A. Russell, G. Hellawell. Northwick Park Hospital, UK
Aim: There is increasing evidence that inﬂammation plays a role in cancer
development. We aimed to compare the predictive value of inﬂammation-
based prognostic scores and haematological values in differentiating non-
muscle invasive (NMIBC) and muscle invasive (MIBC) bladder cancer.
Methods: Bladder cancer cases from 01/2011-12/2013 were analysed
retrospectively. Patient/tumour characteristics, prognostic scores
(Neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR) and platelet-
to-lymphocyte ratio (PLR)) and haematology results were analysed.
Results: 227 patients were included: 176 and 51 in the NMIBC and MIBC
groups, respectively. Groups were signiﬁcantly different (p<0.05) with
regards to age, tumour grade, size, NLR, dNLR, PLR, albumin and white cell,
neutrophil, lymphocyte and platelet counts.
Of the prognostic scores, dNLR (threshold>2.32) had the greatest area
under the ROC curve of 0.725 (Sensitivity 56.9%, Speciﬁcity 79.4%) as
compared to NLR (0.710) and PLR (0.642) and was included in multivariate
analysis. Mean dNLR was 1.86±0.85 in NMIBC and 2.95±2.04 in MIBC.
Multivariate logistic regression analysis identiﬁed tumour grade (OR
19.968, 95%CI 5.008-79.614, p<.0001*) and dNLR (OR 2.260, 95%CI 1.032-
4.947, p¼0.041*) as independent predictors of MIBC.
Conclusion: Our comparison indicates that dNLR may provide a simple,
cost-effective marker for MIBC that can be performed at time of cystos-
copy, thereby assisting in treatment planning.
0259: HOSPITAL ADMISSIONS WITH SEPSIS AFTER TRUS-GUIDED
PROSTATE BIOPSY: ITS INCIDENCE AND BACTERIAL CHARACTERISTICS
IN BOLTON, UK
Z. Zhou*, K. Edwards, M. Pantelides. Royal Bolton Hospital, UK
Aim: Transrectal ultrasound (TRUS)-guided prostate needle biopsy is a
diagnostic procedure for prostate cancer. We aim to investigate incidence
and bacterial characteristics of post-biopsy sepsis.
Methods: A retrospective analysis of medical records was performed in
1105 patients that underwent a 12-core TRUS-guided prostate biopsy at
our hospital over a ﬁve-year period from January 2009 to December 2013.
Cases in which patients admitted with sepsis within 14 days after the bi-
opsy were investigated.
Results: Overall, 20 out of 1105 patients (1.81%) were admitted with sepsis
within 7±3.68 days after the biopsy. All patients received ciproﬂoxacin
prophylaxis for 3 days. 15 patients (1.36%) had positive microbial culture.
Escherichia coli (E. coli) grew in samples from 9 patients (60%), Entero-
coccus species in 2 patients (13.3%), non-E. coli coliforms in 5 patients
(33.3%).One patient had different bacteria cultured from urine and blood
samples. Fluoroquinolone-resistant bacteria were conﬁrmed in 10 patients
(62.5%). Resistance to trimethoprim, co-amoxiclav and tazocin was 43.8%,
